PEEP Titration and Lung Recruitment Potential Assessed by 3D EIT
2 other identifiers
observational
50
1 country
1
Brief Summary
In a population of ARDS patients, we explore the influence of different PEEP levels on regional ventilation distribution, ventilation homogeneity, and the center of ventilation, optimal PEEP and lung recruitment potential as well as the extent of lung collapse and overdistension as detected by 3D-EIT.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2024
CompletedFirst Submitted
Initial submission to the registry
September 2, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedSeptember 19, 2024
September 1, 2024
2 years
September 2, 2024
September 10, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
OD/CL and optimal PEEP monitored by EIT
Monitoring the lung collapse and overdistension region by EIT at different PEEP levels. Measure the optimal PEEP level based on collapse and overdistension rate.
5-10min
Secondary Outcomes (4)
ventilation distribution monitored by EIT
5-10min
GI monitored by EIT
5-10min
CoV monitored by EIT
5-10min
V/Q monitored by EIT
5-10min
Study Arms (2)
lung recruitment potential assessed by 3D EIT in ARDS
Diagnosis of ARDS was based on the Berlin definition, who have receivied mechanical ventilation. The enrolled patients received a lung recruitment potential assessment by 3D EIT( as the follwoing mentioned )
PEEP titration by 3D EIT for ARDS
Diagnosis of ARDS was based on the Berlin definition, who have receivied mechanical ventilation. The enrolled patients received a lung PEEP tirtation by 3D EIT( as the follwoing mentioned )
Interventions
Patients were ventilated based on the ARDS-Net suggestions. The patients were kept at supine position. The lung recruitment potential assessed by 3D EIT was as follows: 1. All patients were under pressure control mode (driving pressure 12-15 cmH2O with a tidal volume of 6-8 ml/kg predicted body weight, respiration rate12-15 bpm). 2. PEEP was switched to a zero end-expiratory pressure (ZEEP) for 10 min, and FiO2 was titrated to obtain peripheral oxygen saturation (SpO2 ) \> 90%. 3. PEEP was stepwise increase from 0 to 15 cmH2O PEEP in steps of 5cm H2O every 3min.And 3D EIT was used to assess lung recruitment potential.
Patients were ventilated based on the ARDS-Net suggestions. The patients were kept at supine position. The PEEP titriatino by 3D EIT fwas as follows: 1. All patients were under pressure control mode (driving pressure 12-15 cmH2O with a tidal volume of 6-8 ml/kg predicted body weight, respiration rate12-15 bpm). 2. RM: PEEP was switched to a 21cmH2O for 2min, and FiO2 was titrated to obtain peripheral oxygen saturation (SpO2 ) ≥90%. 3. PEEP was stepwise decrease from 21 to 0 cmH2O PEEP in steps of 3cm H2O every 2min. 4. 3D EIT was used to monitor regional ventilation distribution during PEEP titration.
Eligibility Criteria
Patients with ARDS on mechanical ventilation.
You may qualify if:
- patients on mechanical ventilation.
- Diagnosis of ARDS was based on the Berlin definition
- lung recruitment potential assessment and PEEP titration was proper for the ARDS patients determined by the attending doctor
You may not qualify if:
- Under 18 years of age.
- Pregnant women;
- Ribcage malformation
- Any contraindication to the use of EIT (e.g. automatic implantable cardioverter defibrillator, and implantable pumps).
- Hemodynamic instability, unable to tolerate high PEEP;
- High-risk individuals with pneumothorax, mediastinal emphysema, etc.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences,
Beijing, Beijing Municipality, 100730, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Huaiwu He, PhD
Department of Critical Care Medicine, Peking Union Medical College, Peking Union Medical College Hospital
- STUDY DIRECTOR
Yun Long, PhD
Department of Critical Care Medicine, Peking Union Medical College, Peking Union Medical College Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 2, 2024
First Posted
September 19, 2024
Study Start
January 1, 2024
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
September 19, 2024
Record last verified: 2024-09